Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2020/43 of 17 January 2020 amending Regulation (EU) No 37/2010 to classify the substance ciclesonide as regards its maximum residue limit (Text with EEA relevance)
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification βCiclesonide The sum of ciclesonide and desisobutyryl-ciclesonide, measured as desisobutyryl-ciclesonide after hydrolysis of ciclesonide to desisobutyryl-ciclesonide Equidae 0,6 ΞΌg/kg 4 ΞΌg/kg 0,6 ΞΌg/kg 0,6 ΞΌg/kg Muscle Fat Liver Kidney Not for use in animals from which milk is produced for human consumption Corticoides/Glucocorticoidesβ
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.